Tumor cell counting using an image analysis program for MIB-1 immunohistochemistry.
暂无分享,去创建一个
M Jimbo | M Ide | M. Yamamoto | M. Jimbo | O Kubo | M Yamamoto | O. Kubo | M. Ide
[1] K. Takakura,et al. Gamma knife radiosurgery for brain tumors: postirradiation volume changes compared with preradiosurgical growth fractions. , 1996, Neurologia medico-chirurgica.
[2] C C Chang,et al. Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. , 1988, Journal of neurosurgery.
[3] M Bibbo,et al. Quantitation of estrogen receptor content and Ki-67 staining in breast carcinoma by the microTICAS image analysis system. , 1987, Analytical and quantitative cytology and histology.
[4] G. Pinkus,et al. Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining. , 1989, The American journal of pathology.
[5] M. Yamamoto,et al. Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index. , 1995, Neurologia medico-chirurgica.
[6] M. Prados,et al. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. , 1989, Journal of neurosurgery.
[7] H. Wakimoto,et al. Prognostic significance of Ki‐67 labeling indices obtained using MIB‐1 monoclonal antibody in patients with supratentorial astrocytomas , 1996, Cancer.
[8] D. Ellison,et al. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[9] M. Jimbo,et al. MIB‐1 staining index and peritumoral brain edema of meningiomas , 1996, Cancer.
[10] T. Visakorpi,et al. Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samples , 1994, The Journal of pathology.
[11] D. Benjamin,et al. Proliferating cell nuclear antigen (PCNA) and pediatric tumors: assessment of proliferative activity. , 1991, Pediatric pathology.
[12] J W Bacus,et al. Biological grading of breast cancer using antibodies to proliferating cells and other markers. , 1989, The American journal of pathology.
[13] M. Koike,et al. Correlation between bromodeoxyuridine‐labeling indices and patient prognosis in cerebral astrocytic tumors of adults , 1991, Cancer.
[14] M. Prados,et al. Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. , 1992, Neurosurgery.
[15] F. Berger,et al. Image analysis applied to proliferating cells in malignant lymphoma. , 1988, Cytometry.
[16] D. Page,et al. Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. , 1992, Human pathology.
[17] C Lesty,et al. Comparative quantitative study of Ki-67 antibody staining in 78 B and T cell malignant lymphoma (ML) using two image analyser systems. , 1992, Pathology, research and practice.